Intellia Therapeutics GAAP EPS of -$0.91 misses by $0.11, revenue of $7.16M misses by $2.61M

Open the sourceReported by Seeking Alpha, seekingalpha.com, 5 November 2026

Not scored

Not investment advice. Muhabbit scores how much a story may matter, not which way to trade.

Muhabbit only has the headline for this one. The full report is at seekingalpha.com.